Implementation Grant Funding Opportunity Open
IMPORTANT: The grant program operates on a rolling basis and applications may be submitted at any time, with quarterly reviews.
Learn More
Implementation Grant Funding Opportunity Open
Qualifying* small and medium-sized US manufacturers, that received IAC or Combined Heat and Power Technical Assistance Partnership assessments between 2018 and 2024, can now apply for grants for implementation of assessment recommendations up 50% of qualifying* project costs with a maximum of $300,000 per manufacturer.
IMPORTANT: The grant program now operates on a rolling basis and applications may be submitted at any time through the year, with quarterly reviews.
*See Full Grant Solicitation for full qualification and selection details.
24
matching assessments| SIC | 2836 | Biological Products Exc. Diagnostic |
|---|
| ID | Year | Products | Reccs | Plant Energy Costs | Recommended Savings |
|---|---|---|---|---|---|
| SD0629 | 2023 |
SD0629 | 2023
Processed Plasma
|
5 | $513,576 | $73,378 |
| SD0626 | 2023 |
SD0626 | 2023
Antibodies, Cell Therapies
|
6 | $1,515,916 | $238,831 |
| SD0625 | 2023 |
SD0625 | 2023
Antibodies, Cell Therapies
|
5 | $562,294 | $112,789 |
| MZ0268 | 2019 |
MZ0268 | 2019
injectable animal vaccines
|
7 | $3,659,679 | $515,044 |
| WM0115 | 2017 |
WM0115 | 2017
Thrombin API (coagulant)
|
5 | $600,194 | $28,296 |
| CO0696 | 2014 |
CO0696 | 2014
Pharmaceuticals
|
4 | $214,679 | $16,250 |
| SF0442 | 2014 |
SF0442 | 2014
Peptides
|
6 | $132,637 | $24,769 |
| NC0470 | 2012 |
NC0470 | 2012
Pharmaceuticals
|
11 | $9,614,576 | $1,449,569 |
| DL0062 | 2010 |
DL0062 | 2010
Animal Vaccines
|
13 | $1,906,755 | $69,582 |
| SU0300 | 2010 |
SU0300 | 2010
Biological Cultures
|
5 | $896,067 | $82,629 |
| SD0413 | 2009 |
SD0413 | 2009
Biopharmaceuticals
|
12 | $1,944,781 | $370,368 |
| IA0411 | 2007 |
IA0411 | 2007
Animal Vaccines
|
8 | $601,379 | $30,610 |
| UU0074 | 2004 |
UU0074 | 2004
Cell culture media
|
6 | $486,003 | $62,970 |
| CO0521 | 2003 |
CO0521 | 2003
Biopharmaceuticals
|
6 | $2,434,152 | $121,980 |
| AM0431 | 2003 |
AM0431 | 2003
Life science products
|
11 | $166,993 | $41,760 |
| LM0046 | 2003 |
LM0046 | 2003
pharmaceutical products
|
13 | $2,139,036 | $616,603 |
| CO0520 | 2003 |
CO0520 | 2003
Biopharmaceuticals
|
5 | $906,336 | $25,174 |
| IA0295 | 2002 |
IA0295 | 2002
Industrial enzymes
|
5 | $3,486,284 | $159,827 |
| OR0389 | 2001 |
OR0389 | 2001
Culture Media
|
5 | $58,987 | $334,057 |
| SD0083 | 1994 |
SD0083 | 1994
Small Joint Prosthetics & Passive Motion Devices
|
11 | $82,077 | $35,315 |
| IA0037 | 1992 |
IA0037 | 1992
ANIMAL VACCINES
|
6 | $1,180,459 | $68,904 |
| KU0273 | 1989 |
KU0273 | 1989
ANIMAL HEALTH PRODUCTS
|
5 | $416,659 | $46,426 |
| KU0266 | 1988 |
KU0266 | 1988
ANIMAL VACCINES, SERUMS
|
9 | $134,620 | $17,378 |
| KU0175 | 1985 |
KU0175 | 1985
RABIES VACCINE
|
9 | $71,918 | $5,837 |